LCI40
LCI40 is an orally active dual PI3K/BRD4 inhibitor (PI3Kα IC50 = 0.071 μM, PI3Kβ IC50 = 0.17 μM, PI3Kγ IC50 = 0.66 μM, PI3Kδ IC50 = 0.072 μM, BRD4 BD1 IC50 = 0.19 μM, and BRD4 BD2 IC50 = 1.88 μM. LCI40 inhibits phosphorylation of pAKT (S473) and suppresses c-MYC levels in mantle cell lymphoma cells. LCI40 displays immunomodulatory capacity with minimal toxicity to normal mouse immune cells. LCI40 can be used for the research of mantle cell lymphoma.
For research use only. We do not sell to patients.
- Formula: C23H20N2O4
- Molecular Weight:388.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
BRD4 (BD2) 1.88 μM (IC50) |
BRD4 (BD1) 0.19 μM (IC50) |
PI3Kγ 0.66 μM (IC50) |
PI3Kα 0.071 μM (IC50) |
PI3Kβ 0.17 μM (IC50) |
In Vitro
LCI40 (1.0 μM) is highly selective for PI3K family enzymes and PIK3CA mutants[1].
LCI40 (1.0 μM) is highly selective for BET family bromodomains, particularly the BD1 domains of BRD4, BRD3, BRD2, and BRDT[1].
LCI40 (48 h) potently reduces cell viability in human Mino (IC50 = 357 nM) and JeKo-1 (IC50 = 519 nM) mantle cell lymphoma cell lines[1].
LCI40 (0.1-1 μM; 2 h) dose-dependently inhibits PI3K/AKT signaling (pAKTS473) and reduces c-MYC protein expression in IgM-stimulated human Mino mantle cell lymphoma cells[1].
LCI40 (0.5 μM; 48 h) interferes with IL-4-mediated alternative macrophage activation in mouse BMDMs by suppressing M2 marker expression and metabolic reprogramming[1].
LCI40 (0.1-5 μM; 1 h pretreatment) dose-dependently restrains CD3/CD28-mediated mouse pan-T cell activation and proliferation, reduces activation marker and effector gene expression, and has micromolar cytotoxicity to resting T cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:IgM-stimulated human Mino mantle cell lymphoma cells
-
Concentration:0.1; 0.5; 1 μM
-
Incubation Time:2 h
-
Result:Dose-dependently inhibited phosphorylation of AKT at S473.
Reduced c-MYC protein levels.
Parmacokinetics
| Species | Dose | Route | T1/2 | Tmax | Cmax | AUC0-last | AUC0-∞ | Vz/F | CL/F |
|---|---|---|---|---|---|---|---|---|---|
| Mice[1] | 20 mg/kg | p.o. | 2.5 h | 0.3 h | 336.5 ng/mL | 153.7 ng·h/mL | 159.2 ng·h/mL | 472.6 L/kg | 128.1 L/h/kg |
Chemical Information
-
Molecular Weight 388.42
-
Formula C23H20N2O4
-
SMILES
O=C1C=C(N2CCOCC2)OC3=C1C=CC=C3C4=CC(C(OC)=CC=N5)=C5C=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)